Oleic acid in olive oil: From a metabolic framework toward a clinical perspective

Current Pharmaceutical Design

Volumn 17, Issue 8, 2011, Pages 831-843

  Bermudez, Beatriz ^a   Lopez, Sergio ^a   Ortega, Almudena ^a   Varela, Lourdes M ^a   Pacheco, Yolanda M ^a   Abia, Rocio ^a   Muriana, Francisco J G ^a  

^a INSTITUTO DE LA GRASA   (Spain)

Author keywords

Cardiovascular risk factors; Oleic acid; Olive oil; Postprandial state

Indexed keywords

INSULIN; LIPOPROTEIN; OLEIC ACID; OLIVE OIL;

BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIETARY INTAKE; DRUG ABSORPTION; EMULSION; ESTERIFICATION; HEMOSTASIS; HUMAN; INFLAMMATION; INSULIN RELEASE; LIPOPROTEIN SECRETION; MICELLE; NONHUMAN; NUTRITION; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; HEMOSTASIS; HUMANS; INFLAMMATION MEDIATORS; INSULIN; LIPOPROTEINS; MODELS, BIOLOGICAL; OLEIC ACID; PLANT OILS; POSTPRANDIAL PERIOD; RISK FACTORS;

EID: 79958240885     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211795428957     Document Type: Review

References (147)

1. Frankel EN. Nutritional and biological properties of extra virginolive oil. J Agric Food Chem 2011; 59: 785-792.
2. Zarrouk W, Baccouri B, Taamalli W, et al. Oil fatty acid compositionof eighteen Mediterranean olive varieties cultivated under thearid conditions of Boughrara (southern Tunisia). Grasas Aceites 2009; 60: 498-506.
3. Dag A, Kerem Z, Yogev N, et al. Influence of time of harvest andmaturity index on olive oil yield and quality. Sci Hort 2011; 127:358-366.
4. Lisa M, Holcapek M, Bohac M. Statistical evaluation of triacylglycerolcomposition in plant oils based on high-performance liquidchromatography-atmospheric pressure chemical ionizationmass spectrometry data. J Agric Food Chem 2009; 57: 6888-6898.
5. Abia R, Pacheco YM, Perona JS, et al. The metabolic availabilityof dietary triacylglycerols from two high oleic oils during the postprandialperiod does not depend on the amount of oleic acid ingestedby healthy men. J Nutr 2001; 131: 59-65.
6. Abia R, Pacheco YM, Montero E, et al. Distribution of fatty acidsfrom dietary oils into phospholipid classes of triacylglycerol-richlipoproteins in healthy subjects. Life Sci 2003; 72:1643-1654.
7. Lopez-Miranda J, Perez-Jimenez F, Ros E, et al. Olive oil andhealth: summary of the II international conference on olive oil andhealth consensus report, Jaén and Córdoba (Spain) 2008. Nutr MetabCardiovasc Dis 2010; 20: 2842-94.
8. US Food and Drug Administration. Press Release P04-100. November1, 2004. http://www.fda.gov/bbs/topics/news/2004/NEW01129.htlm (last access: October 28, 2006).
9. Berglund L, Lefevre M, Ginsberg HN, et al. Comparison of monounsaturatedfat with carbohydrates as a replacement for saturatedfat in subjects with a high metabolic risk profile: studies in the fastingand postprandial states. Am J Clin Nutr 2007; 86: 1611-1620.
10. Muriana FJG, Villar J, Ruiz-Gutierrez V. Intake of olive oil canmodulate the transbilayer movement of human erythrocyte membranecholesterol. Cell Mol Life Sci 1997; 53: 496-500.
11. Kelly CM, Smith RD, Williams CM. Dietary monounsaturatedfatty acids and haemostasis. Proc Nutr Soc 2001; 60: 161-170.
12. Soriguer F, Esteva I, Rojo-Martinez G, et al. Oleic acid from cookingoils is associated with lower insulin resistance in the generalpopulation (Pizarra study). Eur J Endocrinol 2004; 150: 33-39.
13. Ruiz-Gutierrez V, Muriana FJG, Guerrero A, et al. Plasma lipids,erythrocyte membrane lipids and blood pressure of hypertensivewomen after ingestion of dietary oleic acid from two differentsources. J Hypertens 1996; 14: 1483-1490.
14. Mesa MD, Aguilera CM, Gil A. Importance of lipids in the nutritionaltreatment of inflammatory diseases. Nutr Hosp 2006; 21: 30-43.
15. Colette C, Percheron C, Pares-Herbute N, et al. Exchanging carbohydratesfor monounsaturated fats in energy-restricted diets: effectson metabolic profile and other cardiovascular risk factors. Int JObes Relat Metab Disord 2003; 27: 648-656.
16. Nordestgaard BG, Freiberg JJ. Clinical relevance of non-fastingand postprandial hypertriglyceridemia and remnant cholesterol. Curr Vasc Pharmacol 2011 [Epub ahead of print].
17. Lairon D, Defoort C. Effects of Nutrients on Postprandial Lipemia. Curr Vasc Pharmacol 2011 [Epub ahead of print]
18. Alarcon de la Lastra C, Barranco MD, Motilva V, Herrerias JM. Mediterranean diet and health: biological importance of olive oil. Curr Pharm Des 2001; 7: 933-950.
19. McClements DJ, Decker EA, Park Y. Controlling lipid bioavailabilitythrough physicochemical and structural approaches. CritRev Food Sci Nutr 2009; 49: 48-67.
20. Armand M. Lipases and lipolysis in the human digestive tract:where do we stand? Curr Opin Clin Nutr Metab Care 2007; 10:156-164.
21. Lindquist S, Hernell O. Lipid digestion and absorption in early life:an update. Curr Opin Clin Nutr Metab Care 2010; 13:314-320.
22. Wilde PJ, Chu BS. Interfacial & colloidal aspects of lipid digestion. Adv Colloid Interface Sci 2011 [Epub ahead of print].
23. Mu H, Hoy CE. The digestion of dietary triacylglycerols. ProgLipid Res 2004; 43: 105-133.
24. Pafumi Y, Lairon D, de la Porte PL, et al. Mechanisms of inhibitionof triacylglycerol hydrolysis by human gastric lipase. J BiolChem 2002; 277: 28070-280709.
25. Hand KV, Bruen CM, O'Halloran F, Giblin L, Green BD. Acuteand chronic effects of dietary fatty acids on cholecystokinin expression,storage and secretion in enteroendocrine STC-1 cells. MolNutr Food Res 2010; 54:S93-S103.
26. Miled N, Canaan S, Dupuis L, et al. Digestive lipases: from threedimensionalstructure to physiology. Biochimie 2000; 82: 973-986.
27. Haiker H, Lengsfeld H, Hadvary P, Carriere F. Rapid exchange ofpancreatic lipase between triacylglycerol droplets. Biochim BiophysActa 2004; 1682: 72-79.
28. Wong H, Schotz MC. The lipase gene family. J Lipid Res 2002;43: 993-999.
29. Lowe ME. The triglyceride lipases of the pancreas. J Lipid Res 2002; 43: 2007-2016.
30. Liou AP, Lu X, Sei Y, et al. The G-Protein-Coupled ReceptorGPR40 Directly Mediates Long-Chain Fatty Acid-Induced Secretionof Cholecystokinin. Gastroenterology 2011; 140: 903-912.
31. Krzeminski R, Gorinstein S, Leontowicz H, et al. Effect of differentolive oils on bile excretion in rats fed cholesterol-containingand cholesterol-free diets. J Agric Food Chem 2003; 51: 5774-5779.
32. Glatzle J, Darcel N, Rechs AJ, Kalogeris TJ, Tso P, Raybould HE. Apolipoprotein A-IV stimulates duodenal vagal afferent activity toinhibit gastric motility via a CCK1 pathway. Am J Physiol RegulIntegr Comp Physiol 2004; 287: R354-R359.
33. Van Citters GW, Lin HC. Ileal brake: neuropeptidergic control ofintestinal transit. Curr Gastroenterol Rep 2006; 8: 367-373.
34. Ohtani N, Sasaki I, Naito H, et al. Mediators for fat-induced ilealbrake are different between stomach and proximal small intestine inconscious dogs. J Gastrointest Surg 2001; 5: 377-382.
35. Jakob S, Zabielski R, Mosenthin R, et al. Influence of intraduodenallyinfused olive and coconut oil on postprandial exocrine pancreaticsecretions of growing pigs. J Anim Sci 2001; 79:477-485.
36. Serrano P, Yago MD, Mañas M, Calpena R, Mataix J, Martinez-Victoria E. Influence of type of dietary fat (olive and sunflower oil)upon gastric acid secretion and release of gastrin, somatostatin, andpeptide YY in man. Dig Dis Sci 1997; 42: 626-633.
37. West SD, Mercer DW. Cholecystokinin-induced gastroprotection: areview of current protective mechanisms. Dig Dis Sci 2004; 49:361-369.
38. Konturek JW, Hengst K, Konturek SJ, Sito E, Stachura J, DomschkeW. Physiological role of cholecystokinin in gastroprotectionin humans. Am J Gastroenterol 1998; 93: 2385-90.
39. Black DD. Development and physiological regulation of intestinallipid absorption. I. Development of intestinal lipid absorption: cellularevents in chylomicron assembly and secretion. Am J PhysiolGastrointest Liver Physiol 2007; 293: G519-G524.
40. Berry SE. Triacylglycerol structure and interesterification ofpalmitic and stearic acid-rich fats: an overview and implications forcardiovascular disease. Nutr Res Rev 2009; 22: 3-17.
41. Renaud SC, Ruf JC, Petithory D. The positional distribution offatty acids in palm oil and lard influences their biologic effects inrats. J Nutr 1995; 125: 229-237.
42. Abia R, Perona JS, Pacheco YM, Montero E, Muriana FJG, Ruiz-Gutierrez V. Postprandial triacylglycerols from dietary virgin oliveoil are selectively cleared in humans. J Nutr 1999; 129: 2184-2191.
43. Ruiz-Gutierrez V, Perona JS, Pacheco YM, et al. Incorporation ofdietary triacylglycerols from olive oil and high-oleic sunflower oilinto VLDL triacylglycerols of hypertensive patients. Eur J ClinNutr 1999; 53: 687-693.
44. Storch J, Thumser AE. Tissue-specific functions in the fatty acidbindingprotein family. J Biol Chem 2010; 285: 32679-32683.
45. Besnard P, Niot I, Poirier H, et al. New insights into the fatty acidbindingprotein (FABP) family in the small intestine. Mol Cell Biochem 2002; 239: 139-147.
46. Nassir F, Wilson B, Han X, Gross RW, Abumrad NA. CD36 isimportant for fatty acid and cholesterol uptake by the proximal butnot distal intestine. J Biol Chem 2007; 282: 19493-19501.
47. Mansbach CM, Siddiqi SA The biogenesis of chylomicrons. AnnuRev Physiol 2010; 72: 315-333.
48. Mansbach CM 2nd, Gorelick F. Development and physiologicalregulation of intestinal lipid absorption. II. Dietary lipid absorption,complex lipid synthesis, and the intracellular packaging and secretionof chylomicrons. Am J Physiol Gastrointest Liver Physiol 2007; 293: G645-G650.
49. Coleman RA, Lee DP. Enzymes of triacylglycerol synthesis andtheir regulation. Progr Lipid Res 2004; 43: 134-176.
50. Lairon D. Macronutrient intake and modulation on chylomicronproduction and clearance. Atheroscler Suppl 2008; 9: 45-48.
51. Berge RK, Madsen L, Vaagenes H, et al. In contrast with docosahexaenoicacid, eicosapentaenoic acid and hypolipidaemic derivativesdecrease hepatic synthesis and secretion of triacylglycerol bydecreased diacylglycerol acyltransferase activity and stimulation offatty acid oxidation. Biochem J 1999; 343: 191-197.
52. Ou J, Tu H, Shan B, et al. Unsaturated fatty acids inhibit transcriptionof the sterol regulatory element binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci USA 2001; 98: 6027-6032.
53. Luchoomun J, Hussain MM. Assembly and secretion of chylomicronsby differentiated Caco-2 cells. Nascent triglycerides and preformedphospholipids are preferentially used for lipoprotein assembly. J Biol Chem 1999; 274: 19565-19572.
54. Yli-Jokipii KM, Schwab US, Tahvonen RL, et al. Triacylglycerolmolecular weight and to a lesser extent, fatty acid positional distribution,affect chylomicron triacylglycerol composition in women. JNutr 2002; 132: 924-929.
55. Aoe S, Yamamura J, Matsuyama H, et al. The positional distributionof dioleoyl-palmitoyl glycerol influences lymph chylomicrontransport, composition and size in rats. J Nutr 1997; 127: 1269-1273.
56. Perez-Martinez P, Ordovas JM, Garcia-Rios A, et al. Consumptionof diets with different type of fat influences triacylglycerols-richlipoproteins particle number and size during the postprandial state. Nutr Metab Cardiovasc Dis 2011; 21: 39-45.
57. Silva KD, Kelly CN, Jones AE, et al. Chylomicron particle sizeand number, factor VII activation and dietary monounsaturatedfatty acids. Atherosclerosis. 2003; 166: 73-84.
58. Van Greevenbroek MMJ, Robertus-Teunissen MG, Erkelens DW,de Bruin JWA. Lipoprotein secretion by intestinal Caco-2 cells isaffected differently by trans and cis unsaturated fatty acids: effectof carbon chain length and position of the double bond. Am J ClinNutr 1998; 68: 561-567.
59. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfastingtriglycerides and risk of myocardial infarction, ischemicheart disease, and death in men and women. JAMA 2007; 298:299-308.
60. Jackson KG, Robertson MD, Fielding BA, Frayn KN, Williams CM. Olive Oil increases the number of triacylglycerol-rich chylomicronparticles compared with others oils: an effect retainedwhen a second standard meal is fed. Am J Clin Nutr 2002; 76: 942-949.
61. Mekki N, Charbonnier M, Borel P, et al. Butter differs from oliveoil and sunflower oil in its effects on postprandial lipemia and triacylglycerol-rich lipoproteins after single mixed meals in healthyyoung men. J Nutr 2002; 132: 3642-3649.
62. Pacheco YM, Bermudez B, Lopez S, et al. Ratio of oleic topalmitic acid is a dietary determinant of thrombogenic and fibrinolyticfactors during the postprandial state in men. Am J Clin Nutr 2006; 84: 342-349.
63. Lopez S, Bermudez B, Pacheco YM, et al. Dietary oleic andpalmitic acids modulate the ratio of triacylglycerols to cholesterolin postprandial triacylglycerol-rich lipoproteins in men and cell viabilityand cycling in human monocytes. J Nutr 2007; 137: 1999-2005.
64. Bergouignan A, Momken I, Schoeller DA, et al. Metabolic fate ofsaturated and monounsaturated dietary fats: the Mediterranean dietrevisited from epidemiological evidence to cellular mechanisms. Prog Lipid Res 2009; 48: 128-147.
65. Tholstrup T, Sandstrom B, Bysted A, Holmer G. Effect of 6 dietaryfatty acids on the postprandial lipid profile, plasma fatty acids,lipoprotein lipase, and cholesterol ester transfer activities in healthyyoung men. Am J Clin Nutr 2001; 73: 198-208.
66. Lichtenstein L, Mattijssen F, de Wit NJ, et al. Angptl4 protectsagainst severe proinflammatory effects of saturated fat by inhibitingfatty acid uptake into mesenteric lymph node macrophages. Cell Metab 2010; 12: 580-592.
67. Huang J, Qian HY, Li ZZ, et al. Role of endothelial lipase in atherosclerosis. Transl Res 2010; 156: 1-6.
68. Heeren J, Niemeier A, Merkel M, Beisigel U. Endothelial-derivedlipoprotein lipase is bound to postprandial triglyceride-rich lipoproteinsand mediates their hepatic clearance in vivo. J Mol Med 2002;80: 576-584.
69. Chung BH, Cho BHS, Liang P, et al. Contribution of postprandiallipemia to the dietary fat-mediated changes in endogenous lipoprotein-cholesterol concentrations in humans. Am J Clin Nutr 2004;80: 1145-1158.
70. Patel S, Puranik R, Nakhla S, et al. Acute hypertriglyceridaemia inhumans increases the triglyceride content and decreases the antiinflammatorycapacity of high density lipoproteins. Atherosclerosis 2009; 204: 424-428.
71. Viola P, Audisio M. Olive oil and health. International Olive OilCouncil: Madrid 1987.
72. Cicero AF, Nascetti S, Lopez-Sabater MC, et al. Changes in LD Lfatty acid composition as a response to olive oil treatment are inverselyrelated to lipid oxidative damage: The EUROLIVE study. JAm Coll Nutr 2008; 27: 314-3120.
73. Keys A. Coronary heart disease in seven countries. Circulation 1970; 41: 1-211.
74. Christakis G, Severinghaus EL, Maldonado Z, Kafatos F, HashimSA. Crete: A study in the metabolic epidemiology of coronary heartdisease. Am J Cardiol 1965; 15: 320-332.
75. Seymour PA, Sander M. Historical perspective: beginnings of thebeta-cell: current perspectives in beta-cell development. Diabetes 2011; 60: 364-376.
76. Pedrini MT, Niederwanger A, Kranebitter M, et al. Postprandiallipaemia induces an acute decrease of insulin sensitivity in healthymen independently of plasma NEFA levels. Diabetologia 2006; 49:1612-1618.
77. Tentolouris N, Arapostathi C, Perrea D, Kyriaki D, Revenas C, Katsilambros N. Differential effects of two isoenergetic meals richin saturated or monounsaturated fat on endothelial function in subjectswith type 2 diabetes. Diabetes Care 2008; 31: 2276-2278.
78. Lopez S, Bermudez B, Abia R, Muriana FJG. The influence ofmajor dietary fatty acids on insulin secretion and action. Curr OpinLipidol 2010; 21: 15-20.
79. Deguil J, Pineau L, Rowland Snyder EC, et al. Modulation of lipidinducedER stress by fatty acid shape. Traffic 2011; 12: 349-362.
80. Cantley J, Biden TJ. Targeting triglyceride/fatty acid cycling in β-cells as a therapy for augmenting glucose-stimulated insulin secretion. Islets 2010; 2: 127-129.
81. Pinnick K, Neville M, Clark A, Fielding B. Reversibility of metabolicand morphological changes associated with chronic exposureof pancreatic islet beta-cells to fatty acids. J Cell Biochem 2010;109: 683-692.
82. Wrede CE, Buettner R, Wobser H, et al. Systematic analysis of theinsulinotropic and glucagonotropic potency of saturated and monounsaturatedfatty acid mixtures in rat pancreatic islets. Horm MetabRes 2007; 39: 482-488.
83. Moon JH, Lee JY, Kang SB, et al. Dietary monounsaturated fattyacids but not saturated fatty acids preserve the insulin signalingpathway via IRS-1/PI3K in rat skeletal muscle. Lipids 2010; 45:1109-1116.
84. Misra A, Singhal N, Khurana L. Obesity, the metabolic syndrome,and type 2 diabetes in developing countries: role of dietary fats andoils. J Am Coll Nutr 2010; 29: S289-S301.
85. Lopez S, Bermudez B, Pacheco YM, et al. Distinctive postprandialmodulation of β-cell function and insulin sensitivity by dietary fats,MUFA versus SFA. Am J Clin Nutr 2008; 88: 638-644.
86. Sandoo A, van Zanten JJ, Metsios GS, et al. The endothelium andits role in regulating vascular tone. Open Cardiovasc Med J 2010;4: 302-312.
87. Duran WN, Breslin JW, Sanchez FA. The NO cascade, eNOSlocation, and microvascular permeability. Cardiovasc Res 2010; 87:254-261.
88. Grassi D, Desideri G, Ferri C. Cardiovascular risk and endothelialdysfunction: the preferential route for atherosclerosis. Curr Pharm Biotechnol 2011 [Epub ahead of print].
89. Gkaliagkousi E, Ferro A. Nitric oxide signalling in the regulationof cardiovascular and platelet function. Front Biosci 2011; 16:1873-1897.
90. Rocha M, Apostolova N, Hernandez-Mijares A, et al. Oxidativestress and endothelial dysfunction in cardiovascular disease: mitochondria-targeted therapeutics. Curr Med Chem 2010; 17: 3827-3841.
91. Tang EH, Vanhoutte PM. Endothelial dysfunction: a strategic targetin the treatment of hypertension? Pflugers Arch 2010; 459: 995-1004.
92. Layne J, Majkova Z, Smart EJ, et al. Caveolae: A regulatory platformfor nutritional modulation of inflammatory diseases. J NutrBiochem 2011 [Epub ahead of print].
93. Couloubaly S, Delomenie C, Rousseau D, et al. Fatty acid incorporationin endothelial cells and effects on endothelial nitric oxidesynthase. Eur J Clin Invest 2007; 37: 692-699.
94. Tousoulis D, Papageorgiou N, Antoniades C, et al. Acute effects ofdifferent types of oil consumption on endothelial function, oxidativestress status and vascular inflammation in healthy volunteers. Br J Nutr 2010; 103: 43-49.
95. Fuentes F, Lopez-Miranda J, Perez-Martinez P, et al. Chronic effects of a high-fat diet enriched with virgin olive oil and a low-fatdiet enriched with alpha-linolenic acid on postprandial endothelialfunction in healthy men. Br J Nutr 2008; 100: 159-165.
96. Stabler T, Kenjale A, Ham K, et al. Potential mechanisms for reduceddelivery of nitric oxide to peripheral tissues in diabetes mellitus. Ann N Y Acad Sci 2010; 1203: 101-106.
97. Ergul A. Endothelin-1 and diabetic complications: Focus on thevasculature. Pharmacol Res 2011 [Epub ahead of print].
98. Chrysant SG, Chrysant GS. Effectiveness of lowering blood pressureto prevent stroke versus to prevent coronary events. Am J Cardiol 2010; 106: 825-829.
99. Lawes CM, Vander Hoorn S, Rodgers A; International Society ofHypertension. Global burden of blood-pressure-related disease,2001. Lancet 2008; 371: 1513-1518.
100. Mancia G, Grassi G. Management of essential hypertension. BrMed Bull 2010; 94: 189-199.
101. Rossi GP, Seccia TM, Pessina AC. Secondary hypertension: theways of management. Curr Vasc Pharmacol 2010; 8: 753-768.
102. Rontoyanni VG, Chowienczyk PJ, Sanders TA. Postprandial lipaemiadoes not affect resting haemodynamic responses but doesinfluence cardiovascular reactivity to dynamic exercise. Br J Nutr 2010; 104: 863-871.
103. Daskalova DC, Kolovou GD, Panagiotakos DB, et al. Increase inaortic pulse wave velocity is associated with abnormal postprandialtriglyceride response. Clin Cardiol 2005; 28: 577-583.
104. Phillips LK, Peake JM, Zhang X, et al. The effect of a high-fatmeal on postprandial arterial stiffness in men with obesity and type2 diabetes. J Clin Endocrinol Metab 2010; 95: 4455-4459.
105. Blendea MC, Bard M, Sowers JR, Winer N. High-fat meal impairsvascular compliance in a subgroup of young healthy subjects. Metabolism 2005; 54: 1337-1344.
106. Teres S, Barcelo-Coblijn G, Benet M, et al. Oleic acid content isresponsible for the reduction in blood pressure induced by olive oil. Proc Nat Acad Sci USA 2008; 105: 13811-13816.
107. Vogler O, Casas J, Capo D, et al. The Gbetagamma dimer drivesthe interaction of heterotrimeric Gi proteins with nonlamellarmembrane structures. J Biol Chem 2004; 279: 36540-36545.
108. Harris DM, Cohn HI, Pesant S, Eckhart AD. GPCR signalling inhypertension: role of GRKs. Clin Sci 2008; 115: 79-89.
109. Brinks HL, Eckhart AD. Regulation of GPCR signaling in hypertension. Biochim Biophys Acta 2010; 1802: 1268-1275.
110. Alemany R, Vogler O, Teres S, et al. Antihypertensive action of 2-hydroxyoleic acid in SHRs via modulation of the protein kinase Apathway and Rho kinase. J Lipid Res 2006; 47: 1762-1770.
111. Papamichael CM, Karatzi KN, Papaioannou TG, et al. Acute combinedeffects of olive oil and wine on pressure wave reflections:another beneficial influence of the Mediterranean diet antioxidants? J Hypertens 2008; 26: 223-229.
112. Chiu JJ, Chien S. Effects of disturbed flow on vascular endothelium:pathophysiological basis and clinical perspectives. PhysiolRev 2011; 91: 327-387.
113. Baker RG, Hayden MS, Ghosh S. NF-κB, inflammation, and metabolicdisease. Cell Metab 2011; 13: 11-22.
114. Profumo E, Buttari B, Tosti ME, et al. Identification of IP-10 andIL-5 as proteins differentially expressed in human complicated anduncomplicated carotid atherosclerotic plaques. Int J ImmunopatholPharmacol 2010; 23: 775-782.
115. Erbel C, Dengler TJ, Wangler S, et al. Expression of IL-17A inhuman atherosclerotic lesions is associated with increased inflammationand plaque vulnerability. Basic Res Cardiol 2011; 106: 125-134.
116. Haverslag R, Pasterkamp G, Hoefer IE. Targeting adhesion moleculesin cardiovascular disorders. Cardiovasc Hematol Disord DrugTargets 2008; 8: 252-260.
117. Lu HH, Sheng ZQ, Wang Y, Zhang L. Levels of soluble adhesionmolecules in patients with various clinical presentations of coronaryatherosclerosis. Chin Med J 2010; 123: 3123-3126.
118. Wang YI, Schulze J, Raymond N, et al. Endothelial inflammationcorrelates with subject triglycerides and waist size after a high-fatmeal. Am J Physiol Heart Circ Physiol 2011; 300: H784-H791.
119. Benitez MB, Cuniberti L, Fornari MC, et al. Endothelial and leukocyteadhesion molecules in primary hypertriglyceridemia. Atherosclerosis 2008; 197: 679-687.
120. Stanojevic NB, Ivanovic ZJ, Djurovic S, et al. Lack of associationbetween low HDLcholesterol and elevated circulating cellular adhesionmolecules in normolipidemic CAD patients and healthy subjects. Int Heart J 2005; 46: 593-600.
121. Pacheco YM, Lopez S, Bermudez B, et al. A meal rich in oleic acidbeneficially modulates postprandial sICAM-1 and sVCAM-1 innormotensive and hypertensive hypertriglyceridemic subjects. JNutr Biochem 2008; 19: 200-205.
122. De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelialactivation. Am J Clin Nutr 2000; 71: S213-S223.
123. Nicholls SJ, Lundman P, Harmer JA, et al. Consumption of saturatedfat impairs the anti-inflammatory properties of high-densitylipoproteins and endothelial function. J Am Coll Cardiol 2006; 48:715-720.
124. Marschang P, Götsch C, Kirchmair R, et al. Postprandial, but notpostabsorptive low-density lipoproteins increase the expression ofintercellular adhesion molecule-1 in human aortic endothelial cells. Atherosclerosis 2006; 186: 101-6.
125. Alipour A, van Oostrom AJ, Izraeljan A, et al. Leukocyte activationby triglyceride-rich lipoproteins. Arterioscler Thromb VascBiol 2008; 28: 792-797.
126. Varela LM, Ortega A, Bermudez B, et al. A high-fat meal promoteslipid-load and apolipoprotein B-48 receptor transcriptionalactivity in circulating monocytes. Am J Clin Nutr 2011 [Epubahead of print].
127. Mohanty P, Ghanim H, Hamouda W, et al. Both lipid and proteinintakes stimulate increased generation of reactive oxygen speciesby polymorphonuclear leukocytes and mononuclear cells. Am JClin Nutr 2002; 75: 767-772.
128. Yeop Han C, Kargi AY, Omer M, et al. Differential effect of saturatedand unsaturated free fatty acids on the generation of monocyteadhesion and chemotactic factors by adipocytes: dissociationof adipocyte hypertrophy from inflammation. Diabetes 2010; 59:386-396.
129. Harvey JA, Walker CL, Pavlina TM, et al. Long-chain saturatedfatty acids induce pro-inflammatory responses and impact endothelialcell growth. Clin Nutr 2010; 29: 492-500.
130. Krogmann A, Staiger K, Haas C, et al. Inflammatory response ofhuman coronary artery endothelial cells to saturated long-chainfatty acids. Microvasc Res 2011; 81: 52-59.
131. Bellido C, Lopez-Miranda J, Blanco-Colio LM, et al. Butter andwalnuts, but not olive oil, elicit postprandial NF-κB activation inperipheral mononuclear blood cells from healthy male volunteers. Am J Clin Nutr 2004; 80: 1487-1491.
132. Jimenez-Gomez Y, Lopez-Miranda J, Blanco-Colio LM, et al. Olive oil and walnut breakfasts reduce the postprandial inflammatoryresponse in mononuclear cells compared with a butter breakfastin healthy men. Atherosclerosis 2009; 204: 70-76.
133. Butenas S, Orfeo T, Mann KG. Tissue factor activity and functionin blood coagulation. Thromb Res 2008; 122: S42-S46.
134. Holy EW, Tanner FC. Tissue factor in cardiovascular diseasepathophysiology and pharmacological intervention. Adv Pharmacol 2010; 59: 259-292.
135. Zorio E, Gilabert-Estelles J, España F, et al. Fibrinolysis: the key tonew pathogenetic mechanisms. Curr Med Chem 2008; 15: 923-929.
136. Dupont DM, Madsen JB, Kristensen T, et al. Biochemical propertiesof plasminogen activator inhibitor-1. Front Biosci 2009; 14:1337-1361.
137. Sambola A, Fuster V, Badimon JJ. Role of coronary risk factors inblood thrombogenicity and acute coronary syndromes. Rev EspCardiol 2003; 56: 1001-1009.
138. Kälsch T, Elmas E, Nguyen XD, et al. Alimentary lipemia enhancesprocoagulatory effects of inflammation in patients with ahistory of acute myocardial infarction complicated by ventricularfibrillation. Int J Cardiol 2008; 123: 131-137.
139. Duttaroy, AK. Postprandial activation of hemostatic factors: Role of dietary fatty acids. Prostaglandins Leukot Essent Fatty Acids 2005; 72: 381-391.
140. Lindman AS, Müller H, Seljeflot I, et al. Effects of dietary fatquantity and composition on fasting and postprandial levels of coagulationfactor VII and serum choline-containing phospholipids. Br J Nutr 2003; 90: 329-36.
141. Miller GJ. Dietary fatty acids and the haemostatic system. Atherosclerosis 2005; 179: 213-227.
142. Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1(PAI-1): a key factor linking fibrinolysis and age-related subclinicaland clinical conditions. Cardiovasc Ther 2010; 28: e72-e91.
143. Delgado-Lista J, Lopez-Miranda J, Cortes B, et al. Chronic dietaryfat intake modifies the postprandial response of hemostatic markersto a single fatty test meal. Am J Clin Nutr 2008; 87: 317-322.
144. Sanders TA, Oakley FR, Cooper JA, Miller GJ. Influence of astearic acid-rich structured triglyceride on postprandial lipemia,factor VII concentrations, and fibrinolytic activity in healthy subjects. Am J Clin Nutr 2001; 73: 715-721.
145. Chrusciel P, Goch A, Banach M, et al. Circadian changes in thehemostatic system in healthy men and patients with cardiovascular diseases. Med Sci Monit 2009; 15: RA203-RA208.
146. Kinlay S, Schwartz GG, Olsson AG, et al. Endogenous tissueplasminogen activator and risk of recurrent cardiac events after anacute coronary syndrome in the MIRACL study. Atherosclerosis 2009; 206: 551-555.
147. Georgieva AM, Cate HT, Keulen ET, et al. Prothrombotic markersin familial combined hyperlipidemia: evidence of endothelial cellactivation and relation to metabolic syndrome. Atherosclerosis 2004; 175: 345-351.